HIV Vaccine Development: Immunological and Biological Challenges
joint with Twenty Years of HIV Research: From Discovery to Understanding
Organizer(s): Richard A. Koup, David C. Montefiori and Brigitte AutranDate: March 29 - April 04, 2003
Location: Fairmont Banff Springs, Banff, AB, Canada
Our efforts to curtail the worldwide spread of HIV infection are bolstered by the fact that we now have new information on the molecular and immunological basis of HIV infection. An intimate understanding of immunological control of HIV, and mechanisms by which HIV escapes that control, form the basis of developing novel strategies to prevent infection and disease. Many new vaccine products are now being tested in animal and human trials. Unlike other infections that have been prevented by vaccination, HIV specifically infects and destroys a key component of the immune response to intracellular pathogens. In addition, HIV is exquisitely capable of evading neutralizing antibody responses. All attempts to eliminate HIV from infected individuals have failed. The overall goal of this symposium will be to integrate the newest information on the molecular and cellular biology of HIV infection, the immune response to that infection, and the results of clinical trials of vaccine products. The program will identify the advances that have been made, and the challenges that remain, in developing a vaccine against HIV. The interaction between basic and applied scientists will foster accelerated research and development on HIV vaccines.
Discounted Abstract Deadline: December 31 2002
Discounted Registration Deadline: January 29 2003
We gratefully acknowledge additional support for this conference from: